The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells-Reference-Cited by-同舟云学术

The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells

Published:2020-07-09 Issue:3 Volume:20 Page:3053-3060
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Schcolnik‑Cabrera Alejandro¹,Chavez‑Blanco Alma¹,Dominguez‑Gomez Guadalupe¹,Juarez Mandy¹,Lai Donna²,Hua Sheng²,Tovar Armando³,Diaz‑Chavez Jose¹,Duenas‑Gonzalez Alfonso¹

Affiliation:

1. Division of Basic Research, National Cancer Institute, Mexico City 14080, Mexico

2. Molecular Biology Facility, University of Sydney, Sydney, NSW 2006, Australia

3. Nutrition Physiology Department, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City 14080, Mexico

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia drives CBR4 down‐regulation promotes gastroenteropancreatic neuroendocrine tumors via activation mammalian target of rapamycin mediated by fatty acid synthase;Journal of Cell Communication and Signaling;2024-06-22

2. Mitochondrial remodeling in colorectal cancer initiation, progression, metastasis, and therapy: A review;Pathology - Research and Practice;2023-06

3. Orlistat Induces Ferroptosis in Pancreatic Neuroendocrine Tumors by Inactivating the MAPK Pathway;Journal of Cancer;2023

4. Lonidamine loaded Poly(ethylene glycol)–block–poly(ε-caprolacton) nanocarriers inhibited the proliferation of colorectal cancer cells through G0/G1 cell cycle arrest;Journal of Drug Delivery Science and Technology;2022-11

5. Metabolic Pathways Regulating Colorectal Cancer: A Potential Therapeutic Approach;Current Pharmaceutical Design;2022-10